Reported about 1 month ago
Pfizer's CEO, Dr. Albert Bourla, who gained fame for delivering a COVID-19 vaccine, is now facing criticism as the company's stock prices decline significantly due to miscalculations in vaccine demand and other challenges. Activist investor Starboard Value has taken a stake in Pfizer and accused the company of pressuring former executives to support Bourla, creating tension within the corporate structure. Despite Bourla's ambitious plans and past successes, analysts warn that Pfizer's revenue may decline in the coming years, prompting questions about its leadership and future direction.
Source: YAHOO